KDA Group is a leading solution and service provider to the pharmaceutical market.
Founded in 2009, KDA Group (TSXV:KDA), formely known as AlliancePharma Inc. (TSXV:APA), has been publicly traded since 2015, and formalizes its name change on January 25th 2017.
KDA Group began with organic growth. But after its decision to go public, the company’s growth strategy turned to acquisitions, leveraging its strong operations and results. Its sales have since grown significantly.
KDA Group is an alliance of companies involved in all aspects of the patient’s experience. We believe every patient deserves the best care. To achieve this goal, we’ve established more sound practices and a more efficient system through evidence-based health care, added-value products and services, and patient-centric solutions. KDA Group sets a new standard in the fields of medical education and pharmaceutical services.
The company’s goal is to become a leading solution and service provider to the Canadian and International pharmaceutical market. KDA Group has positioned itself as a strategic partner in pharmaceuticals.
Chief Executive Officer
Strategic advisor, International Business Development
Executive Vice President
Development and integration of technological platforms dedicated to all healthcare professionals.